NYSE:OGN

Organon & Stock Insider Trading

Healthcare > Drug Manufacturers - General

Buy OGN

*Your capital is at risk

$13.56

+0 (+0%)

At Close: Aug 04, 2026

Organon & Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 67.94. In total, the insiders bought 2.6B and sold 105.4M OGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	67.94
● Buy	2.6B shares
● Sell	105.4M shares
73% Buy Activity Moderate Negative Correlation
Sell Signal Low Confidence May 06, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 67.94. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 31, 2026 Sell	Common Stock F-InKind	Drinane Juliana Papa Interim Head Of Mfg & Supply	Officer	2 185 Value: $12.5K
Mar 31, 2026 Buy	Common Stock M-Exempt	Drinane Juliana Papa Interim Head Of Mfg & Supply	Officer	6 378 Value: $38.2K
Mar 31, 2026 Sell	Common Stock F-InKind	Stahler Rachel A Chief Information Officer	Officer	4 217 Value: $24.0K
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Stahler Rachel A Chief Information Officer	Officer	6 555 Value: $39.3K
Mar 31, 2026 Buy	Restricted Stock Units A-Award	Nisita Vittorio Head Of Global Business Svcs	Officer	125 208 Value: $750.0K
Mar 31, 2026 Buy	Common Stock M-Exempt	Nisita Vittorio Head Of Global Business Svcs	Officer	4 606 Value: $27.6K
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Nisita Vittorio Head Of Global Business Svcs	Officer	4 606 Value: $27.6K
Mar 31, 2026 Buy	Common Stock M-Exempt	Holzbaur Lynette SVP And Corporate Controller	Officer	6 715 Value: $40.2K
Mar 31, 2026 Sell	Common Stock F-InKind	Holzbaur Lynette SVP And Corporate Controller	Officer	1 212 Value: $7K
Mar 31, 2026 Buy	Common Stock M-Exempt	Morrissey Joseph T. Jr. Interim CEO	CEO / President	16 789 Value: $100.6K
Mar 31, 2026 Sell	Common Stock F-InKind	Morrissey Joseph T. Jr. Interim CEO	CEO / President	2 221 Value: $12.7K
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Weaver Kirke Gen. Counsel & Corp. Secy.	Officer	6 201 Value: $37.1K
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Weaver Kirke Gen. Counsel & Corp. Secy.	Officer	12 312 Value: $73.7K
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Falcione Aaron Chief Human Resources Officer	Officer	11 193 Value: $67.0K
Mar 31, 2026 Buy	Restricted Stock Units A-Award	Weaver Kirke Gen. Counsel & Corp. Secy.	Officer	183 639 Value: $1.10M
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Walsh Matthew M Chief Financial Officer	C-Suite Officer	12 047 Value: $72.2K
Mar 31, 2026 Sell	Common Stock F-InKind	Falcione Aaron Chief Human Resources Officer	Officer	3 834 Value: $21.9K
Mar 31, 2026 Sell	Common Stock F-InKind	Walsh Matthew M Chief Financial Officer	C-Suite Officer	4 127 Value: $23.5K
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Morrissey Joseph T. Jr. Interim CEO	CEO / President	7 795 Value: $46.7K
Mar 31, 2026 Sell	Common Stock F-InKind	Holzbaur Lynette SVP And Corporate Controller	Officer	1 914 Value: $10.9K
Mar 31, 2026 Sell	Common Stock F-InKind	Nisita Vittorio Head Of Global Business Svcs	Officer	2 875 Value: $16.4K
Mar 31, 2026 Buy	Common Stock M-Exempt	Weaver Kirke Gen. Counsel & Corp. Secy.	Officer	12 312 Value: $73.7K
Mar 31, 2026 Sell	Common Stock F-InKind	Weaver Kirke Gen. Counsel & Corp. Secy.	Officer	1 767 Value: $10.1K
Mar 31, 2026 Buy	Restricted Stock Units M-Exempt	Morrissey Joseph T. Jr. Interim CEO	CEO / President	16 789 Value: $100.6K
Mar 31, 2026 Buy	Common Stock M-Exempt	Holzbaur Lynette SVP And Corporate Controller	Officer	4 252 Value: $25.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ORGANON & CO.

Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology pr...

Read Full Profile Here